Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Prga

Thursday, July 2

ORLSESSION'S 00010*-.-30 11.0012.3370

PL4 Plenary: Biomedical Advances in HIV Research
Chairs: Kim Nichols, F. Waldvogel
Venue: Arena
Time: 09.00-10.30
485 How viruses cause immunosuppression
Rolf Zinkernagel
486 The significance of virus subtypes for epidemiology and pathogenesis
Jaap Goudsmit
487 How HIVfunctions, multiplies and causes disease:
possible new approaches to therapy
Robert Gallo
PPL4 Plenary: Consequences of an Evolving 00
Epidemic
Chairs: Michael H. Merson, Heydee Pellegrini
Venue: Session Hall I
Time: 09.00-10.30
488 From personal to global survival
Javier Luis Hourcade Belloque
489 From personal to global survival
Naisiadet Maina
490 Priorities for public funds: crises in national leadership?
Omwony Ojwok
491 Priorities for public funds: crises in national leadership?
Marina Mahathir
492 Human rights: consequences for the epidemic HIV
Mary Robinson

A41 Vaccine Trials in Humans
Chairs: Vina Churdboonchart, Andrei Kozlov
Venue: Session Hall VII
Time: 11.00-12.30

493 Vaccine trials in humans
Larry Corey
494 Induction of immune responses
Kent Weinhold
495 CD8+CTL induced in AIDS vaccine evaluation group phase I
trials using canarypox vectors (ALVAC) encoding multiple HIV
gene products (vCP125, vCP205, vCP300) given with or without
subunit boost
Thomas Evans*; L. Corey; M.L. Clements-Mann; K. Weinhold;
R.B. Belshe; J.L. Excler; A.M. Duliege, USA
496 A phase I trial of vaccinia-env/gag/pol (TBC-3B) given
by alternative routes, boosted with rgpl20
Michael C. Keefer*; MJ. McElrath; K. Weinhold; G.J. Gorse;
M. Mulligan; D. Francis; D. Panicali, USA
497 HIV-1 cross-clade lymphoproliferative responses
following immunization with recombinant Gp120 SF2
Thippawan Chuenchitra*; S. Ratto-Kim; M. De Souza;
K. Rungruengthanakit; S. Nitayaphan; C. Khamboonruang;
C. Chuenchitra; R.A. Michael; F. Sinangil; A.M. Duliege;
J.G. McNeil; D.L. Birx, Thailand
498 NIAD funding opportunities for AIDS vaccine research:
2 new strategy and programmes
Steve Bende

21192
21199
21201
1/

Pathway Symbols: O Human Rights O Policy

CONFERENCE WORKBOOK

177